An O-Glycosylation of Fibronectin Mediates Hepatic Osteodystrophy Through alpha4beta1 Integrin.
Sens C, Altrock E, Rau K, Klemis V, von Au A, Pettera S, Uebel S, Damm T, Tiwari S, Moser M, Nakchbandi IA
J Bone Miner Res. 2017 Jan;32(1):70-81. doi: 10.1002/jbmr.2916. Epub 2016 Aug 3. PubMed Article
Sens C, Altrock E, Rau K, Klemis V, von Au A, Pettera S, Uebel S, Damm T, Tiwari S, Moser M, Nakchbandi IA
J Bone Miner Res. 2017 Jan;32(1):70-81. doi: 10.1002/jbmr.2916. Epub 2016 Aug 3. PubMed Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 120404 | Fibronectin-human-mutated N-terminal (N) O-Glycosylation site | enables eukaryotic expression of human plasma fibronectin in which the first O-glycosylation site was mutated from threonine to serine |
| 120405 | Fibronectin-human-mutated V2 O-Glycosylation site | enables eukaryotic expression of human plasma fibronectin in which the second O-glycosylation site was mutated from threonine to serine |
| 120406 | Fibronectin-human-mutated V1 O-Glycosylation site | enables eukaryotic expression of human plasma fibronectin in which the third O-glycosylation site was mutated from threonine to serine |
| 120407 | Fibronectin-human-mutated N-terminal (N), V1 and V2 Glycosylation sites | enables eukaryotic expression of human plasma fibronectin in which all three O-glycosylation sites were mutated from threonine to serine |